Rohto Pharmaceutical (Japan)

Rohto Pharmaceutical (Japan)

Rohto Pharmaceutical Co., Ltd. is a multinational corporation specializing in fast-moving consumer goods and pharmaceuticals, headquartered in Ikuno-ku, Osaka, Japan. The company primary focuses on skin and eye care products. They also produce cosmetics, supplements, and over-the-counter medications. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Rohto Pharmaceutical (Japan), Japan, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

68%


Total
Publications

207


Total Open
Publications

140


Total
Citations

3.1K


Open Access
Percentage

68%


Total
Publications

207


Total Open
Publications

140


Total
Citations

3.1K

Wikipedia

Website

download

Breakdown

36% 30% 1% 33%

Publisher Open

36%

Both

30%

Other Platform Open

1%

Closed

33%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618202224262830Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

52

Hybrid 34%

45

No Guarantees 27%

36

Other Platform Open

Domain 92%

59

Other Internet 23%

15

Institution 11%

7

Public 3%

2

Preprint 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
59
DOI
Other Internet
15
Europe PMC
Domain
3
Kyoto University - Kyoto University Research Information Repository
Institution
2
Iwate University - Iwate University Repository
Institution
2
Zenodo
Public
1
Universidad Autónoma de Madrid - Biblos-e Archivo
Institution
1
OSF Preprints - Arabixiv
Preprint
1
Osaka University Knowledge Archive - OUKA
Institution
1
Konstfack University of Arts, Crafts, and Design - Publications
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share